aid: surge-therapeutics
name: SURGE Therapeutics
description: 'SURGE Therapeutics is a clinical-stage biotechnology company based in Cambridge,
  Massachusetts, developing intraoperative cancer immunotherapy. Founded on research from
  Dr. Michael Goldberg''s laboratory at Harvard Medical School, the company''s SURGERx platform
  is an injectable, biodegradable hydrogel placed directly at the site of surgical tumor
  resection to provide extended, localized release of immunotherapy — addressing the
  surgery-induced inflammation that suppresses the immune system and allows residual disease
  to reawaken. Its lead program, SRG-514, completed Phase 1 dose escalation in breast cancer
  patients undergoing surgery and is being prepared for a registrational trial, with an
  additional IND cleared for a Phase 1/2a study in bladder cancer. SURGE has raised a $26M
  Series A and a $32M Series B. It is a therapeutics developer, not a software company, and
  publishes no developer program, API, or machine-readable interface.'
image: https://surgetx.com/wp-content/uploads/2021/06/SURGE_No-Slogan-COLOUR-1024x279.png
url: https://raw.githubusercontent.com/api-evangelist/surge-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Immunotherapy
- Drug Delivery
- Clinical Stage
- Health
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/surge-therapeutics-domain-security.yml
- type: Website
  url: https://surgetx.com/
- type: About
  url: https://surgetx.com/science/
- type: Team
  url: https://surgetx.com/team/
- type: News
  url: https://surgetx.com/news/
- type: Contact
  url: https://surgetx.com/contacts/
- type: LinkedIn
  url: https://www.linkedin.com/company/surge-therapeutics
- type: SecondaryMarket
  url: https://forgeglobal.com/surge-therapeutics_stock/
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    SURGE Therapeutics is a clinical-stage oncology drug developer whose entire web presence
    is a five-page WordPress marketing site (home, science, news, team, contacts); the only
    machine-readable endpoint on surgetx.com is WordPress core's default /wp-json CMS route
    index, and api./developer./docs./portal.surgetx.com are all NXDOMAIN.
  evidence:
  - url: https://surgetx.com/openapi.json
    status: 404
  - url: https://surgetx.com/.well-known/agent-card.json
    status: 404
  - url: https://surgetx.com/.well-known/security.txt
    status: 404
  - url: https://surgetx.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/surgetx
    status: 404
  - url: https://surgetx.com/wp-json
    status: 200
  checked: '2026-08-05'